/GTMS.TO
GTMS.TO Stock - Greenbrook TMS Inc.
Healthcare|Medical - Care FacilitiesTSX
$0.97-15.65%
$0.18 (-15.65%) • Mar 13
45
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.3
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.48
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.07
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GTMS.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.96 – $0.98
TARGET (TP)$1.12
STOP LOSS$0.89
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.79
52W High$7.65
52W Low$0.97
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $69.10M | $52.20M | $43.13M | $35.69M | $21.26M |
| Gross Profit | $6.06M | $24.61M | $5.14M | $8.49M | $2.89M |
| Gross Margin | 8.8% | 47.1% | 11.9% | 23.8% | 13.6% |
| Operating Income | $-28,725,796 | $-22,815,754 | $-17,297,996 | $-10,912,486 | $-4,709,024 |
| Net Income | $-86,713,255 | $-29,512,931 | $-32,469,826 | $-17,732,321 | $-4,958,043 |
| Net Margin | -125.5% | -56.5% | -75.3% | -49.7% | -23.3% |
| EPS | $-3.12 | $-1.91 | $-2.54 | $-1.65 | $-0.62 |
Company Overview
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GTMS.TOBeat Rate
20%
Last 15 quarters
Avg Surprise
-30.9%
EPS vs Estimate
Beats / Misses
3/12
Last 12 quarters
Latest EPS
$-0.59
Q4 2022
EPS Surprise History
Q1 21
-67.7%
$-0.52vs$-0.31
Q2 21
-24.4%
$-0.56vs$-0.45
Q3 21
-6.8%
$-0.47vs$-0.44
Q4 21
-11.1%
$-0.40vs$-0.36
Q1 22
+8.1%
$-0.34vs$-0.37
Q2 22
No data
Q3 22
-5.1%
$-0.41vs$-0.39
Q4 22
-168.2%
$-0.59vs$-0.22
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2022 | Nov 8, 2022 | $-0.22 | $-0.59 | -168.2% | ✗ MISS |
Q3 2022 | Aug 2, 2022 | $-0.39 | $-0.41 | -5.1% | ✗ MISS |
Q2 2022 | May 13, 2022 | — | $-0.44 | — | — |
Q1 2022 | Mar 30, 2022 | $-0.37 | $-0.34 | +8.1% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $-0.36 | $-0.40 | -11.1% | ✗ MISS |
Q3 2021 | Aug 5, 2021 | $-0.44 | $-0.47 | -6.8% | ✗ MISS |
Q2 2021 | May 14, 2021 | $-0.45 | $-0.56 | -24.4% | ✗ MISS |
Q1 2021 | Mar 30, 2021 | $-0.31 | $-0.52 | -67.7% | ✗ MISS |
Q4 2020 | Nov 10, 2020 | $-0.32 | $-0.25 | +21.9% | ✓ BEAT |
Q3 2020 | Aug 4, 2020 | $-0.32 | $-0.35 | -9.4% | ✗ MISS |
Q2 2020 | May 12, 2020 | $-0.30 | $-0.40 | -33.3% | ✗ MISS |
Q1 2020 | Mar 10, 2020 | $-0.30 | $-0.65 | -116.7% | ✗ MISS |
Q4 2019 | Nov 4, 2019 | $-0.17 | $-0.30 | -76.5% | ✗ MISS |
Q3 2019 | Aug 6, 2019 | $-0.25 | $-0.30 | -20.0% | ✗ MISS |
Q2 2019 | May 9, 2019 | $-0.20 | $-0.25 | -25.0% | ✗ MISS |
Q1 2019 | Mar 27, 2019 | $-0.35 | $-0.10 | +71.4% | ✓ BEAT |
Q4 2018 | Nov 12, 2018 | — | $-0.26 | — | — |
Q3 2018 | Sep 27, 2018 | — | $-0.20 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.24 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.17 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GTMS.TO
What is GTMS.TO's current stock price?
Greenbrook TMS Inc. (GTMS.TO) is currently trading at $0.97 per share. The stock has moved -15.65% today.
What is the analyst price target for GTMS.TO?
No analyst price targets are currently available for this stock.
What sector is Greenbrook TMS Inc. in?
Greenbrook TMS Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the TSX exchange.
What is GTMS.TO's market cap?
Greenbrook TMS Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does GTMS.TO pay dividends?
No, Greenbrook TMS Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACST.V
Acasti Pharma Inc.
$0.58
Mkt Cap: $0.0B
AEZS.TO
Aeterna Zentaris Inc.
$8.29
Mkt Cap: $0.0B
HEXO.TO
HEXO Corp.
$0.88
Mkt Cap: $0.0B
HS.CN
HS GovTech Solutions Inc.
$0.53
Mkt Cap: $0.0B
MMEN.CN
MedMen Enterprises Inc.
$0.02
Mkt Cap: $0.0B
NUMI.TO
Numinus Wellness Inc.
$0.05
Mkt Cap: $0.0B
REUN.TO
Reunion Neuroscience Inc.
$1.42
Mkt Cap: $0.0B
SGMD.V
Salona Global Medical Device Corporation
$0.22
Mkt Cap: $0.0B
THNK.V
Think Research Corporation
$0.32
Mkt Cap: $0.0B
VIN.CN
Vinergy Capital Inc.
$0.20
Mkt Cap: $0.0B
Explore stocks similar to GTMS.TO for comparison